Marcy Bolster

Concepts (319)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Rheumatology
18
2022
45
8.040
Why?
Arthritis, Rheumatoid
15
2022
144
3.400
Why?
Rheumatologists
6
2021
14
2.750
Why?
Education, Medical, Graduate
7
2022
208
2.670
Why?
Osteoporosis
6
2017
83
2.330
Why?
Scleroderma, Systemic
21
2018
432
1.930
Why?
Fellowships and Scholarships
6
2021
124
1.840
Why?
Bone Density Conservation Agents
6
2018
41
1.830
Why?
Diphosphonates
3
2018
38
1.420
Why?
Antirheumatic Agents
8
2022
56
1.400
Why?
Curriculum
10
2022
545
1.280
Why?
Internship and Residency
4
2022
583
1.180
Why?
Hypertension, Pulmonary
9
2018
227
1.090
Why?
Clinical Competence
10
2022
3653
1.030
Why?
Health Services Needs and Demand
2
2020
144
0.930
Why?
Pandemics
2
2022
309
0.890
Why?
Glucocorticoids
4
2022
222
0.870
Why?
Humans
76
2022
68792
0.860
Why?
Internal Medicine
2
2022
114
0.830
Why?
Musculoskeletal Pain
1
2018
7
0.740
Why?
Faculty, Medical
2
2020
107
0.740
Why?
Bone Density
2
2017
154
0.730
Why?
Fractures, Stress
2
2015
12
0.720
Why?
Myocardial Infarction
2
2022
790
0.700
Why?
Education, Medical, Continuing
1
2019
132
0.690
Why?
Telemedicine
2
2022
646
0.630
Why?
Aromatase Inhibitors
1
2016
17
0.620
Why?
Autoimmune Diseases
2
2016
179
0.610
Why?
Central Nervous System Sensitization
3
2020
8
0.610
Why?
Adrenal Cortex Hormones
2
2016
174
0.610
Why?
Rheumatic Diseases
1
2016
35
0.600
Why?
Lung Diseases
4
2021
164
0.600
Why?
Giant Cell Tumor of Bone
1
2015
1
0.600
Why?
Denosumab
1
2015
2
0.600
Why?
Symptom Assessment
1
2015
28
0.590
Why?
Pain Threshold
3
2020
50
0.590
Why?
Proton Pump Inhibitors
1
2016
86
0.570
Why?
Serotonin Uptake Inhibitors
1
2016
146
0.570
Why?
Osteoporotic Fractures
1
2014
8
0.570
Why?
Checklist
1
2015
73
0.550
Why?
Bone Neoplasms
1
2015
96
0.550
Why?
Tibia
1
2015
91
0.550
Why?
Consensus
1
2015
194
0.550
Why?
Anticonvulsants
1
2016
221
0.530
Why?
Preventive Health Services
1
2014
82
0.530
Why?
Antibodies, Monoclonal
1
2017
501
0.530
Why?
Fasciitis
2
2009
31
0.530
Why?
Referral and Consultation
1
2016
369
0.520
Why?
Eosinophilia
2
2009
51
0.520
Why?
Interprofessional Relations
1
2015
188
0.510
Why?
Teaching
1
2015
163
0.510
Why?
Lung Diseases, Interstitial
4
2014
101
0.470
Why?
Physician Assistants
3
2019
47
0.410
Why?
Nurse Practitioners
3
2019
87
0.410
Why?
Vertebroplasty
1
2010
16
0.400
Why?
Arthralgia
2
2020
28
0.380
Why?
Pulmonary Fibrosis
6
2012
145
0.360
Why?
Cyclophosphamide
5
2007
127
0.340
Why?
Middle Aged
30
2021
20597
0.340
Why?
Adult
22
2022
20717
0.340
Why?
Risk Factors
8
2022
5494
0.320
Why?
Evidence-Based Medicine
1
2010
430
0.320
Why?
Rheumatoid Factor
2
2020
20
0.320
Why?
Female
40
2021
39962
0.310
Why?
Decision Making
1
2010
392
0.310
Why?
Male
35
2021
36233
0.290
Why?
Randomized Controlled Trials as Topic
1
2010
913
0.290
Why?
Prednisone
2
2022
102
0.280
Why?
Registries
3
2018
704
0.280
Why?
Pain
2
2020
456
0.270
Why?
Pain Measurement
5
2020
325
0.270
Why?
Bronchoalveolar Lavage Fluid
3
2007
118
0.270
Why?
Antibodies, Antineutrophil Cytoplasmic
1
2003
7
0.260
Why?
Granulomatosis with Polyangiitis
1
2003
11
0.260
Why?
United States
7
2022
7025
0.260
Why?
Accreditation
2
2022
73
0.260
Why?
Joints
2
2007
30
0.250
Why?
Cohort Studies
4
2022
2250
0.250
Why?
Aged
17
2021
14503
0.240
Why?
Program Evaluation
2
2016
494
0.240
Why?
Proteinuria
1
2003
133
0.240
Why?
Tomography
1
2002
9
0.240
Why?
Fibromyalgia
1
2022
26
0.230
Why?
Etanercept
1
2021
10
0.230
Why?
Adalimumab
1
2021
14
0.230
Why?
Spectroscopy, Near-Infrared
1
2002
31
0.230
Why?
Feedback
1
2022
89
0.230
Why?
Optics and Photonics
1
2002
30
0.230
Why?
Hemosiderosis
1
2021
8
0.230
Why?
Glomerulonephritis, IGA
1
2021
12
0.230
Why?
Methotrexate
1
2022
90
0.230
Why?
Patient Reported Outcome Measures
2
2020
105
0.220
Why?
Chronic Periodontitis
1
2021
17
0.220
Why?
Personnel Selection
1
2021
35
0.220
Why?
Bone and Bones
1
2002
139
0.220
Why?
Severity of Illness Index
8
2020
1779
0.210
Why?
Myocardial Ischemia
1
2022
170
0.210
Why?
Physicians, Women
1
2020
22
0.210
Why?
Career Mobility
1
2020
33
0.210
Why?
Musculoskeletal System
1
2020
11
0.210
Why?
Gout
1
2020
9
0.210
Why?
Needs Assessment
2
2020
172
0.210
Why?
Tramadol
1
2020
3
0.210
Why?
Immunosuppressive Agents
4
2007
485
0.200
Why?
Raynaud Disease
2
2002
26
0.200
Why?
Lovastatin
1
2020
76
0.200
Why?
Catastrophization
1
2019
4
0.200
Why?
Sarcoidosis
2
2016
75
0.200
Why?
Imaging, Three-Dimensional
1
2002
310
0.200
Why?
Learning
1
2022
183
0.200
Why?
T-Lymphocytes, Cytotoxic
1
2020
83
0.200
Why?
Calcinosis
1
2021
232
0.200
Why?
B-Lymphocytes
1
2021
320
0.200
Why?
Pregnancy Complications
1
2003
274
0.200
Why?
Kidney Failure, Chronic
1
2003
347
0.190
Why?
C-Reactive Protein
1
2020
177
0.190
Why?
Antigens, CD
1
2020
223
0.190
Why?
Treatment Outcome
10
2021
6794
0.190
Why?
Eosinophilia-Myalgia Syndrome
2
1996
22
0.180
Why?
CD4-Positive T-Lymphocytes
1
2020
213
0.180
Why?
Chronic Pain
1
2020
94
0.180
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2020
204
0.180
Why?
Pain Perception
1
2018
20
0.180
Why?
Ultrasonography
1
2020
445
0.170
Why?
Teriparatide
1
2017
7
0.170
Why?
Goals
2
2020
70
0.170
Why?
Bone Diseases, Metabolic
1
2017
29
0.170
Why?
Delivery of Health Care, Integrated
1
2018
77
0.170
Why?
Scleroderma, Diffuse
2
2014
24
0.160
Why?
Systemic Vasculitis
1
2016
1
0.160
Why?
Natriuretic Peptide, Brain
1
2016
97
0.160
Why?
Polymyalgia Rheumatica
1
2016
5
0.160
Why?
Biopsy, Needle
2
2009
201
0.160
Why?
Giant Cell Arteritis
1
2016
9
0.160
Why?
Myositis
1
2016
24
0.150
Why?
Self-Assessment
1
2016
70
0.150
Why?
Expert Testimony
1
2015
44
0.150
Why?
Vitamins
1
2016
130
0.150
Why?
Alcohol Drinking
1
2022
782
0.140
Why?
Scleroderma, Limited
1
2014
5
0.140
Why?
Certification
1
2015
65
0.140
Why?
History, 20th Century
1
2016
248
0.140
Why?
Brassica
1
1994
12
0.140
Why?
Drug Discovery
1
2016
92
0.140
Why?
Plant Oils
1
1994
31
0.140
Why?
Decision Support Techniques
3
1999
3221
0.140
Why?
Biopsy
3
1999
3573
0.140
Why?
Inpatients
1
2016
197
0.140
Why?
Societies, Medical
1
2017
392
0.140
Why?
Cardiovascular Diseases
1
2022
899
0.140
Why?
Prospective Studies
6
2019
3543
0.140
Why?
Data Collection
1
2015
427
0.130
Why?
Neoplasms, Connective Tissue
1
2013
4
0.130
Why?
Dietary Supplements
1
2016
311
0.130
Why?
Vital Capacity
4
2018
39
0.120
Why?
Apoptosis
1
2020
1613
0.120
Why?
Hospitalization
1
2018
895
0.120
Why?
Femoral Fractures
1
2013
45
0.120
Why?
Scleroderma, Localized
2
2009
16
0.120
Why?
Cytokines
1
1997
840
0.120
Why?
Calcium
1
2016
898
0.110
Why?
Lung
2
2014
806
0.110
Why?
Follow-Up Studies
5
2018
3159
0.110
Why?
Vitamin D
1
2016
495
0.110
Why?
Drug Therapy, Combination
2
2003
636
0.110
Why?
Breast Neoplasms
3
1999
4510
0.110
Why?
Cross-Sectional Studies
4
2021
2142
0.110
Why?
Critical Pathways
1
2010
29
0.110
Why?
Fractures, Compression
1
2010
11
0.100
Why?
Selection Bias
1
2010
24
0.100
Why?
Hemodynamics
3
2016
673
0.100
Why?
Spinal Fractures
1
2010
42
0.100
Why?
Pulmonary Artery
1
2012
315
0.100
Why?
Lupus Erythematosus, Systemic
1
2016
712
0.100
Why?
Anesthetics, Local
1
2010
83
0.090
Why?
Disease Progression
2
2016
977
0.090
Why?
Leukocyte Count
1
2007
95
0.090
Why?
Eosinophils
1
2007
56
0.090
Why?
Double-Blind Method
4
2020
1679
0.080
Why?
Antihypertensive Agents
2
2003
479
0.080
Why?
Neutrophils
1
2007
191
0.080
Why?
Survival Rate
4
2018
4060
0.080
Why?
Hypertrophy, Left Ventricular
1
2007
141
0.080
Why?
African Americans
2
2007
1898
0.080
Why?
Diagnosis, Differential
2
2003
1124
0.070
Why?
Sex Factors
2
2020
1231
0.070
Why?
Blood Pressure
1
2012
1366
0.070
Why?
Inflammation
2
2022
976
0.070
Why?
Respiratory Function Tests
3
2012
114
0.070
Why?
Animals
3
2017
20109
0.070
Why?
Gastrointestinal Diseases
1
2005
103
0.070
Why?
Longitudinal Studies
3
2014
1012
0.070
Why?
Pregnancy, High-Risk
1
2003
14
0.060
Why?
Hypertension, Renal
1
2003
27
0.060
Why?
Autoantibodies
1
2006
416
0.060
Why?
Pregnancy Trimester, Second
1
2003
53
0.060
Why?
Radiography, Thoracic
1
2003
97
0.060
Why?
Fetal Death
1
2003
57
0.060
Why?
Incidence
1
2007
1520
0.060
Why?
Quality of Life
3
2007
1419
0.060
Why?
Ulnar Artery
1
2002
5
0.060
Why?
Absorption
1
2002
48
0.060
Why?
Multivariate Analysis
2
2020
1038
0.060
Why?
Age Factors
1
2007
1808
0.060
Why?
Carpal Tunnel Syndrome
1
2001
14
0.060
Why?
Gingival Crevicular Fluid
1
2021
9
0.060
Why?
Single-Blind Method
1
2021
247
0.050
Why?
Videoconferencing
1
2021
43
0.050
Why?
Arterial Occlusive Diseases
1
2002
139
0.050
Why?
Costs and Cost Analysis
3
1999
3217
0.050
Why?
Anti-Citrullinated Protein Antibodies
1
2020
2
0.050
Why?
Chickens
1
2002
229
0.050
Why?
Lymphatic Metastasis
3
1999
3305
0.050
Why?
Epoprostenol
1
2000
70
0.050
Why?
Workplace
1
2021
72
0.050
Why?
Immunohistochemistry
1
2003
1142
0.050
Why?
Pre-Eclampsia
1
2003
197
0.050
Why?
Gout Suppressants
1
2020
7
0.050
Why?
Electronics
1
2020
17
0.050
Why?
Saliva
1
2021
122
0.050
Why?
Uric Acid
1
2020
33
0.050
Why?
Interviews as Topic
1
2021
380
0.050
Why?
Fingers
2
2002
39
0.050
Why?
United Kingdom
1
2020
148
0.050
Why?
Neoplasm Staging
3
1999
3822
0.050
Why?
Skin
1
2003
436
0.050
Why?
Leadership
1
2020
131
0.050
Why?
Tomography, X-Ray Computed
3
2017
2242
0.050
Why?
Linear Models
1
2020
511
0.050
Why?
Models, Theoretical
1
2002
381
0.050
Why?
Arterial Pressure
1
2018
44
0.050
Why?
Fibrosis
1
2020
340
0.040
Why?
Sensitivity and Specificity
3
1999
4741
0.040
Why?
Odds Ratio
1
2020
852
0.040
Why?
Image Processing, Computer-Assisted
1
2002
664
0.040
Why?
Personnel Staffing and Scheduling
1
2018
57
0.040
Why?
Ulna
1
2017
2
0.040
Why?
Radius
1
2017
10
0.040
Why?
Metacarpophalangeal Joint
1
2017
9
0.040
Why?
Young Adult
1
2009
5496
0.040
Why?
Macrophage Inflammatory Proteins
1
1997
3
0.040
Why?
Chemokine CCL4
1
1997
6
0.040
Why?
Chemokine CCL3
1
1997
9
0.040
Why?
Chemokine CCL5
1
1997
22
0.040
Why?
Depression
1
2005
923
0.040
Why?
Pregnancy
1
2003
2231
0.040
Why?
Forecasting
1
2018
267
0.040
Why?
Risk Assessment
1
2003
1934
0.040
Why?
Logistic Models
1
2020
1373
0.040
Why?
Tryptophan
1
1996
62
0.040
Why?
Proportional Hazards Models
1
2018
778
0.040
Why?
Administration, Oral
2
2007
401
0.040
Why?
Surveys and Questionnaires
2
2020
2727
0.040
Why?
Pilot Projects
1
2020
1290
0.040
Why?
Enzyme-Linked Immunosorbent Assay
1
1997
506
0.040
Why?
CREST Syndrome
1
1995
4
0.040
Why?
Echocardiography
1
2018
505
0.040
Why?
Connective Tissue Diseases
1
1995
14
0.040
Why?
Pulmonary Diffusing Capacity
1
2014
12
0.040
Why?
Hospitals, University
2
2006
166
0.040
Why?
Fatty Acids, Monounsaturated
1
1994
29
0.040
Why?
Time Factors
2
2018
4527
0.040
Why?
Total Lung Capacity
2
2007
14
0.040
Why?
Reproducibility of Results
2
2013
2019
0.030
Why?
Cardiac Catheterization
2
2012
407
0.030
Why?
Analgesics, Opioid
1
2020
456
0.030
Why?
Tumor Necrosis Factor-alpha
1
2017
624
0.030
Why?
Familial Primary Pulmonary Hypertension
1
2014
23
0.030
Why?
Syndrome
1
1994
253
0.030
Why?
Peptide Fragments
1
2016
468
0.030
Why?
Educational Measurement
1
2015
244
0.030
Why?
Exercise Test
1
2014
230
0.030
Why?
Cognition Disorders
1
1996
321
0.030
Why?
Osteomalacia
1
2013
8
0.030
Why?
Paraneoplastic Syndromes
1
2013
15
0.030
Why?
Bone Nails
1
2013
32
0.030
Why?
South Carolina
2
2013
2636
0.030
Why?
North Carolina
1
2013
215
0.030
Why?
Motor Activity
1
1996
603
0.030
Why?
Fracture Fixation, Intramedullary
1
2013
33
0.030
Why?
Cognition
1
1996
479
0.030
Why?
Program Development
1
2013
236
0.030
Why?
Retrospective Studies
2
2020
6845
0.030
Why?
Quality Improvement
1
2013
390
0.020
Why?
Forced Expiratory Volume
1
2007
80
0.020
Why?
Bronchoalveolar Lavage
1
2007
13
0.020
Why?
Tomography, Spiral Computed
1
2007
52
0.020
Why?
Leukopenia
1
2006
23
0.020
Why?
Health Status Indicators
1
2007
113
0.020
Why?
Drug Administration Schedule
1
2007
547
0.020
Why?
Age of Onset
1
2006
184
0.020
Why?
Disability Evaluation
1
2007
292
0.020
Why?
Regression Analysis
1
2006
718
0.020
Why?
Magnetic Resonance Imaging
1
2013
2134
0.020
Why?
Sympathectomy
1
2002
27
0.010
Why?
Ulcer
1
2002
31
0.010
Why?
Hypesthesia
1
2001
5
0.010
Why?
Paresthesia
1
2001
9
0.010
Why?
Median Nerve
1
2001
6
0.010
Why?
Saphenous Vein
1
2002
65
0.010
Why?
Health Status
1
2005
419
0.010
Why?
Antibodies, Antinuclear
1
2002
167
0.010
Why?
Echocardiography, Doppler
1
2000
87
0.010
Why?
Cardiac Output
1
2000
124
0.010
Why?
Vascular Surgical Procedures
1
2002
170
0.010
Why?
Infusions, Intravenous
1
2000
314
0.010
Why?
Pulmonary Wedge Pressure
1
2000
102
0.010
Why?
Anticoagulants
1
2002
354
0.010
Why?
Swimming
1
1996
35
0.010
Why?
Aged, 80 and over
1
2006
4729
0.010
Why?
Maze Learning
1
1996
133
0.010
Why?
Reaction Time
1
1996
197
0.010
Why?
Body Weight
1
1996
532
0.010
Why?
Kidney Diseases
1
1997
292
0.010
Why?
Analysis of Variance
1
1996
1021
0.010
Why?
Prognosis
1
1997
2044
0.010
Why?
Mice, Inbred C57BL
1
1996
2671
0.010
Why?
Disease Models, Animal
1
1996
2448
0.010
Why?
Mice
1
1996
8108
0.000
Why?
Bolster's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (319)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_